Atlas Trials

NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma

Clinical trial NCT03462316 · COMPLETED

Trial details

NCT number
NCT03462316
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bone SarcomaSoft Tissue Sarcoma
Start date
2018-05-21
Primary completion
2020-04-15
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.